illudin s has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cimmino, A; Dasari, R; Evidente, A; Evidente, M; Kiss, R; Kornienko, A; Lefranc, F; Mathieu, V; van Otterlo, WA; Vurro, M | 1 |
| Estes, LA; Kashinatham, A; Kelner, MJ; McMorris, TC; Staake, MD | 1 |
| Liu, X; Pietsch, KE; Sturla, SJ | 1 |
| Gong, J; Neels, JF; Pietsch, KE; Sturla, SJ; Yu, X | 1 |
1 review(s) available for illudin s and Neoplasms
| Article | Year |
|---|---|
Toward a Cancer Drug of Fungal Origin.
Topics: Androstadienes; Animals; Antineoplastic Agents; Aphidicolin; Biological Products; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; Disease Models, Animal; Drug Design; Drug Resistance, Neoplasm; Fatty Acids, Unsaturated; Female; Fungi; Humans; Macrolides; Male; Mice; Neoplasms; Polycyclic Sesquiterpenes; Sesquiterpenes; Trichothecenes; Wortmannin | 2015 |
3 other study(ies) available for illudin s and Neoplasms
| Article | Year |
|---|---|
Hydroxyurea derivatives of irofulven with improved antitumor efficacy.
Topics: Acetylation; Agaricales; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Humans; Hydroxyurea; Mice, Inbred BALB C; Neoplasms; Polycyclic Sesquiterpenes; Sesquiterpenes | 2016 |
Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes.
Topics: Agaricales; Alkylation; Antineoplastic Agents; Antioxidants; Cell Survival; Cysteine; Enzyme Inhibitors; Glutathione Peroxidase; HeLa Cells; Humans; Neoplasms; Polycyclic Sesquiterpenes; Selenocysteine; Sesquiterpenes; Spiro Compounds; Thioredoxin-Disulfide Reductase | 2011 |
Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates.
Topics: Alcohol Dehydrogenase; Alkylation; Animals; Antibiotics, Antineoplastic; Biotransformation; Borohydrides; Cell Line, Tumor; Cell Survival; DNA; Enzyme Activation; Humans; NADP; Neoplasms; Polycyclic Sesquiterpenes; Rats; Sesquiterpenes; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2011 |